Sandoz announces generic Differin gel

PRINCETON, N.J. — Sandoz on Monday announced the introduction of its adapalene 0.3% gel, a generic version of Differin gel, 0.3% from Galderma Labs. Adapalene gel is a retinoid and is used for the topical treatment of acne vulgaris in patients ages 12 years and older.



"Sandoz is proud to market a high-quality, affordable generic version of this important topical therapy,” said Peter Goldschmidt, president of Sandoz U.S. “This launch further broadens our strong offering of differentiated generic dermatology products in the United States.”



Sandoz will market the gel through a collaboration with Tolmar Inc., which owns the abbreviated new drug application for the product and was the first company to receive FDA approval for a generic equivalent.



Sandoz will market the adapalene 0.3% gel in 45 gram tubes. U.S. sales for Differin gel 0.3% in 45-g tubes was approximately $87 million for the 12 months ending December 2013, according to IMS Health.